Investigation of the anticancer and apoptotic effect of Micromeria congesta ‎under in vitro conditions and detection of related genes by real-time PCR

Document Type : Original Article


1 Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Harran University, Şanlıurfa, Turkiye

2 Department of Genetics, Faculty of Veterinary Medicine, Harran University, Şanlıurfa, Turkiye

3 Department of Biochemistry, Faculty of Medicine, Harran University, Şanlıurfa, Turkiye

4 Department of Educational Sciences, Faculty of Education, Harran University, Şanlıurfa, Turkiye‎


At the present time cancer is one of the biggest health problems and because of the problems encountered in its treatment, alternative treatment methods of herbal origin are researched. In this study, the cytotoxic effects of the essential oil extracted from the Micromeria congesta plant on various cancer cells (A549, ECC-1, HCT-116, HELA, HGC-27, MDA-MB-231, SNU-423, U20S, DLD-1, PC-3) and normal cells (BEAS-2B, CRL-4010) have been examined. Anticancer mechanism of action has been particularly examined on gastric cancer (HGC-27; IC50: 15.84 µg mL-1), on which essential oil showed a high cytotoxic effect. In the study, the cytotoxic effect and the apoptotic effect have been applied by MTT and flow cytometric annexin-V methods, respectively. The apoptotic gene expression (caspase 3, caspase 9, MMP2, MMP9, ACTB) real-time PCR content analysis has been performed with gas chromatography mass spectrometry (GC-MS). M. congesta essentials oil has the highest cytotoxic effect on gastric cancer (HGC-27) cells, decreases MMP2 and MMP9 expressions, and induces apoptosis with increasing the expression of caspase 3 and caspase 8 genes. In addition, it has been determined that piperitenone oxide (40.00 - 45.00%), pulegone (11.00%) and cyclohexanone (18.00 - 19.00%) are the major components of M. congesta essentials oil. In conclusion, it has been determined that the compounds found in high amounts in M. congesta plant induces apoptosis by affecting the expression of compound genes and thus can have the potential to be an alternative drug in the treatment of gastric cancer.



    1. Chakraborty C, Sharma AR, Sharma G, et al. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget 2018; 9(11): 10164-10174.
    2. Bresailer RS. Malignant and premalignant lesions of the colon. In: Friedman SL, McQuaid KR, Grendell JH (Eds). Current diagnosis and treatment in gastroenterolgy. 2nd New York, USA: McGraw Hill Medical 2002; 407-435.
    3. Mork CN, Faller DV, Spanjaard RA. Loss of putative tumorsuppressor EI24/PIG8 confers resistance to etoposide. FEBS Letters 2007; 581(28): 5440-5444.
    4. Vetoshkina TV, Dubskaya TY, Fomina TI, et al. Toxic effect of vepesid on morphology and function of the rat liver. Bull Exp Biol Med 2007; 143 : 21-23.
    5. Borovskaya TG, Goldberg VE, Shchemerova YA, et al. Evaluation of the progeny of rats treated with topoisomerase II inhibitor vepesid. Bull Exp Biol Med 2006; 141(5): 515-518.
    6. Korkmaz S. Evaluation of cytotoxic effects of paclitaxel, quercetin and berberine, A549, HeLa, HT-29, MCF-7 and NIH3T3 in cell culture. PhD Thesis. Anadolu University Health Institute of Sciences. Anadolu, Turkey: 2002.
    7. Lee KH. Anticancer drug design based on plant-derived natural products, J Biomed Sci 1999; 6(4): 236-250.
    8. El-Shazly MM, El-Zayat EM, Hermersdörfer H. Insecticidal activity, mammalian cytotoxicity and mutagenicity of an ethanolic extract from Nerium oleander (Apocynaceae), Ann Appl Biol 2000; 136(2): 153-157.
    9. Zhao QW, Li B, Weber N, et al. Estrogen-like effects of ethanol extracts from several Chinese legumes on MCF-7 cell. Eur Food ResTechnol 2005; 221(6): 828-833.
    10. Miller H. The story of Taxol: Nature and the politics in the pursuit of an anti-cancer drug. Nat Med 2001; 7: 148. :10.1038/84570.
    11. Pommier Y, Redon C, Rao VA, et al. Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat Res 2003; 532(1-2): 173-203.
    12. Kayser O, Quax WJ. Medicinal plant biotechnology: From basic research to industrial applications. New York, USA: Wiley 2006; 1-8
    13. Stagos D, Amoutzias GD, Matakos A, et al. Chemoprevention of liver cancer by plant polyphenols. Food Chem Toxicol 2012; 50(6): 2155-2170.
    14. Kitdamrongtham W, Manosroi A, Akazawa H, et al. Potent anti-cervical cancer activity: Synergistic effects of Thai medicinal plant in recipe N040 selected from the MANOSROI III database. J Ethnopharmacol 2013; 149(1): 288-296.
    15. Ziech D, Anestopoulos I, Hanafi R, et al. Pleiotrophic effects of natural products in ROS-induced carcino-genesis: the role of plant-derived natural products in oral cancer chemoprevention. Cancer Lett 2012; 327(1-2): 16-25.
    16. Ginwala R, Bhavsar R, Chigbu DI, et al. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants (Basel) 2019; 8(2): 35. doi: 10.3390/antiox8020035.
    17. Rawat D, Shrivastava S, Naik RA, et al. An overview of natural plant products in the treatment of hepatocellular carcinoma. Anticancer Agents Med Chem 2018; 18 (13): 1838 -1859.
    18. Faydaoğlu E, Sürücüoğlu MS The use and economic importance of medicinal and aromatic plants from past to present [Turkish]. Kastamonu Univ J For Fac 2011; 11(1): 52-67.
    19. Dar RA,Shahnawaz M, Qazi PH General overview of medicinalplants: A review. J Phytopharm 2017; 6(6): 349-351.
    20. Alwan S, El Omari K, Soufi H, et al. Evaluation of the antibacterial activity of Micromeria barbata in Lebanon. J Essent Oil-Bear Plants 2016; 19(2): 321-327.
    21. Sonboli, A. Biological activity of various extracts and phenolic content of Micromeria persica and M. hedgei.Res J Pharmacogn 2015; 2(4): 27-31.
    22. Akan H, Aydoğdu M, Korkut MM, et al. An ethnobotanical research of the Kalecik mountain area (Şanlıurfa, South-East Anatolia). Bio Divers Conserv 2013; 6(2): 84-90.
    23. Herken EN, Celik A, Aslan M, et al. The constituents of essential oil: antimicrobial and antioxidant activity of Micromeria congesta & Hausskn. ex Boiss. from East Anatolia. J Med Food 2012; 15(9): 835-839.
    24. Mishra RK, Kumar A, Shukla AC, et al. Quantitative and rapid antibacterial assay of Micromeria biflora leaf essential oil against dental caries causing bacteria using phylogenetic approach. J Ecobiotechnol 2010; 2(4): 22-26.
    25. Çarıkçı, S. The essential oil components of five Micromeria species grown in Anatolia. Balıkesir Üniv Fen Bilim Enst derg. 2013; 15(2): 73-79.
    26. Kirimer N, Özek T, Baser KHC. Composition of the essential oil of Micromeria congesta. J Essen Oil Res 1991; 3(6): 387-393.
    27. Adams RP. Identification of essential oil components by gas chromatography/mass spectrometry, 4th Carol Stream, USA: Allured Publishing Corp. 2007: 268.
    28. Pore MM, Hiltermann TJN, Kruyt FA. Targeting apoptosis pathways in lung cancer. Cancer Lett 2013; 332(2): 359-368.
    29. Turan İ, Demir S, Aliyazıcıoğlu R, et al. Evaluation of antioxidant and cytotoxic properties of Primula vulgaris leaf extract [Turkish]. KSU J Nat Sci 2017; 20(4): 361-367.
    30. Koç LY. The effect of some plant extracts on adenosine deaminase enzyme in cancerous tissues with their antimicrobial, antioxidant and cytotoxic effects [Turkish]. PhD Thesis. Ankara University Institute of Science, Ankara, Turkey: 2012.
    31. Alizadeh A, Ranjbaran J. Chemical composition and antimicrobial activity of Micromeria hedgei f. oil from Iran. Nat Prod Res 2017; 31(2): 210-213.
    32. Formisano C, Mignola E, Rigano D, et al . Chemical composition and antimicrobial activity of the essential oil from aerial parts of Micromeria fruticulosa (Bertol.) Grande (Lamiaceae) growing wild in Southern Italy. Flavour Fragr J. 2007; 22(4): 289-292.
    33. Güzey G. Cytotoxic and antiproliferative effects of hypericum perforatum, hypericum montbretti and hypericum origanifolium species on A549, HeLa and NIH 3T3 cell cultures [Turkish]. PhD Thesis. Health Science Institue, Anadolu University, Anadolu, Turkey: 2007.
    34. Di Sotto A, Evandri MG, Mazzanti G. Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay. Mutt Res2008; 653(1-2): 130-133.
    35. Božović M, Pirolli A, Ragno R. Mentha suaveolens Ehrh. (Lamiaceae) essential oil and its main constituent piperitenone oxide: biological activities and chemistry. Molecules 2015; 20(5): 8605-8633.
Volume 13, Issue 1
March 2022
Pages 7-14
  • Receive Date: 21 December 2019
  • Revise Date: 01 February 2020
  • Accept Date: 12 February 2020
  • First Publish Date: 15 December 2021